Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.531 Q1 | 103 | 84 | 319 | 11035 | 1560 | 286 | 4.51 | 131.37 | 42.98 | |
2 | CNS and Neurological Disorders - Drug Targets | journal | 0.832 Q2 | 96 | 75 | 356 | 5805 | 1004 | 308 | 3.28 | 77.40 | 42.50 | |
3 | Current Topics in Medicinal Chemistry | journal | 0.788 Q2 | 133 | 231 | 798 | 22201 | 2546 | 687 | 2.90 | 96.11 | 40.28 | |
4 | Current Protein and Peptide Science | journal | 0.666 Q2 | 96 | 121 | 329 | 11284 | 727 | 291 | 2.31 | 93.26 | 39.55 | |
5 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q2 | 52 | 29 | 94 | 2940 | 250 | 91 | 2.75 | 101.38 | 44.35 | |
6 | Current Stem Cell Research and Therapy | journal | 0.577 Q2 | 63 | 95 | 228 | 6944 | 521 | 204 | 2.43 | 73.09 | 40.11 | |
7 | Current Cardiology Reviews | journal | 0.558 Q2 | 58 | 36 | 115 | 2320 | 202 | 103 | 1.76 | 64.44 | 28.31 | |
8 | Mini-Reviews in Medicinal Chemistry | journal | 0.500 Q2 | 107 | 120 | 425 | 10067 | 1162 | 394 | 2.65 | 83.89 | 36.87 | |
9 | Current Clinical Pharmacology | journal | 0.475 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
10 | Reviews on Recent Clinical Trials | journal | 0.361 Q3 | 35 | 43 | 129 | 1922 | 141 | 116 | 1.21 | 44.70 | 41.25 | |
11 | Combinatorial Chemistry and High Throughput Screening | journal | 0.296 Q3 | 70 | 82 | 287 | 3127 | 376 | 259 | 1.22 | 38.13 | 35.29 | |
12 | Current Nanoscience | journal | 0.246 Q3 | 52 | 72 | 245 | 4405 | 392 | 229 | 1.88 | 61.18 | 35.04 | |
13 | Current Computer-Aided Drug Design | journal | 0.216 Q3 | 32 | 40 | 105 | 1649 | 86 | 90 | 0.80 | 41.23 | 31.82 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®